New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

On 16 January 2026, Telix Pharmaceuticals announced that the first U.S. patient had been dosed in BiPASS, a Phase 3 trial ...

A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using ...

A viral claim says cancer can be destroyed without surgery using MRI and extreme cold. Breakthrough or hype? Here's what ...

Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

Full-body MRI scans are gaining popularity, but doctors warn their benefits may not outweigh the risks for healthy, symptom-free individuals. While MRIs can detect certain cancers and abnormalities, ...

Seven years after the activation of the prostate biopsy service using Fusion technology, one of the most advanced innovations ...

A new way to prevent excruciating pain from the side effects of advanced prostate cancer therapy has been developed. Many men with late-stage prostate cancer are given a powerful type of treatment ...

Koelis, SAS ("Koelis" or the "Company", a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, recently announced that the Centers for Medicare & Medicaid ...

A full-body scan every few years, for some, is a small price to pay for a wide-ranging check-up. Is it the right choice for ...

CMS has permanently authorized virtual contrast supervision beginning January 1, 2026, allowing radiologists to oversee contrast injections via real-time audio and video technology. Professional ...